Balloon-Occluded Hepatic Radioembolization with Yttrium-90 (b-TARE) in Selected Patients with Unresectable Heterogeneous Hepatocellular Carcinoma (HCC): A Safe and Effective Approach to Improve the Dose Rate
Leonardo Teodoli, Nicolò Ubaldi, Claudio Trobiani, Federico Cappelli, Sara Ungania, Pierleone Lucatelli, Rosa Sciuto, Giulio Vallati · 2025
Read Balloon-Occluded Hepatic Radioembolization with Yttrium-90 (b-TARE) in Selected Patients with Unresectable Heterogeneous Hepatocellular Carcinoma (HCC): A Safe and Effective Approach to Improve the Dose Rate by Leonardo Teodoli, Nicolò Ubaldi, Claudio Trobiani, Federico Cappelli, Sara Ungania, Pierleone Lucatelli, Rosa Sciuto, Giulio Vallati (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12732101.txt.
Description
Leonardo Teodoli and seven co-authors test in 2025 a balloon-based way to boost radiation care for liver cancer. Some liver tumors are large or spread out, with uneven blood flow that blurs dose spread. Blocking flow with a balloon may focus the dose where it counts.
The study looks back at 63 patients who could not have surgery. Of them, 24 get the balloon method and 39 get the standard method. Scans after care show dose maps in two and three dimensions. Peak dose strength runs higher with the balloon method on the two-way check. The authors read the profile as safer and stronger, though the look-back design calls for care in firm claims.
Catalog record
| CREATOR | Leonardo Teodoli, Nicolò Ubaldi, Claudio Trobiani, Federico Cappelli, Sara Ungania, Pierleone Lucatelli, Rosa Sciuto, Giulio Vallati |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 24 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |